BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9 AND Clinical Outcome
7 results:

  • 1. Predictive Value of ERCC1, ercc2, and XRCC Expression for Patients with Locally Advanced or Metastatic gastric cancer Treated with Neoadjuvant mFOLFOX-4 Chemotherapy.
    Yeh YS; Chen YT; Tsai HL; Huang CW; Ma CJ; Su WC; Huang CM; Huang MY; Hu HM; Lu CY; Wang JY
    Pathol Oncol Res; 2020 Apr; 26(2):1105-1116. PubMed ID: 31077069
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genetic variability of DNA repair mechanisms in chemotherapy treatment outcome of gastric cancer patients.
    Zhong G; Li HK; Shan T; Zhang N
    Genet Mol Res; 2015 Dec; 14(4):17228-34. PubMed ID: 26681216
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Influences of ERCC1, ercc2, XRCC1, GSTP1, GSTT1, and MTHFR polymorphisms on clinical outcomes in gastric cancer patients treated with EOF chemotherapy.
    Liu R; Zhao X; Liu X; Chen Z; Qiu L; Geng R; Guo W; He G; Yin J; Li J; Zhu X
    Tumour Biol; 2016 Feb; 37(2):1753-62. PubMed ID: 26314858
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.
    Xue MH; Li GY; Wu XJ; Zhang CX; Zhang CF; Zhu KX
    Int J Clin Exp Pathol; 2015; 8(5):5563-9. PubMed ID: 26191265
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A genetic variant in ercc2 is associated with gastric cancer prognosis in a Chinese population.
    Chu H; Gu D; Xu M; Xu Z; Gong Y; Gong W; Tang Y; Zhou J; Tong N; Zhang Z; Chen J; Wang M
    Mutagenesis; 2013 Jul; 28(4):441-6. PubMed ID: 23680703
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Xeroderma pigmentosum group D 751 polymorphism as a predictive factor in resected gastric cancer treated with chemo-radiotherapy.
    Zárate RN; Arias F; Bandres E; Cubedo E; Malumbres R; García-Foncillas J
    World J Gastroenterol; 2006 Oct; 12(37):6032-6. PubMed ID: 17009404
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy.
    Ruzzo A; Graziano F; Kawakami K; Watanabe G; Santini D; Catalano V; Bisonni R; Canestrari E; Ficarelli R; Menichetti ET; Mari D; Testa E; Silva R; Vincenzi B; Giordani P; Cascinu S; Giustini L; Tonini G; Magnani M
    J Clin Oncol; 2006 Apr; 24(12):1883-91. PubMed ID: 16622263
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.